[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Artivion Inc (AORT)

Artivion Inc (AORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,396,372
  • Shares Outstanding, K 48,756
  • Annual Sales, $ 441,330 K
  • Annual Income, $ 9,770 K
  • EBIT $ 21 M
  • EBITDA $ 43 M
  • 60-Month Beta 1.25
  • Price/Sales 3.14
  • Price/Cash Flow 25.77
  • Price/Book 3.09

Options Overview Details

View History
  • Implied Volatility 64.00% (-5.88%)
  • Historical Volatility 44.04%
  • IV Percentile 45%
  • IV Rank 9.31%
  • IV High 343.80% on 11/28/25
  • IV Low 35.29% on 12/23/25
  • Expected Move (DTE 8) 0.13 (0.45%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 98
  • Volume Avg (30-Day) 267
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 1,541
  • Open Int (30-Day) 630
  • Expected Range 28.28 to 28.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.11
  • Number of Estimates 1
  • High Estimate $0.11
  • Low Estimate $0.11
  • Prior Year $0.16
  • Growth Rate Est. (year over year) -31.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.83 +24.44%
on 07/14/26
29.33 -3.15%
on 08/12/26
+4.38 (+18.23%)
since 07/13/26
3-Month
19.82 +43.34%
on 06/08/26
29.33 -3.15%
on 08/12/26
+6.18 (+27.80%)
since 05/13/26
52-Week
19.16 +48.28%
on 05/08/26
48.25 -41.12%
on 12/17/25
-15.32 (-35.03%)
since 08/13/25

Most Recent Stories

More News
5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call

5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call

AORT : 28.41 (-0.80%)
AORT Q2 Deep Dive: Product Momentum and Pipeline Expansion Support Positive Outlook

AORT Q2 Deep Dive: Product Momentum and Pipeline Expansion Support Positive Outlook

AORT : 28.41 (-0.80%)
Artivion: Q2 Earnings Snapshot

Artivion: Q2 Earnings Snapshot

AORT : 28.41 (-0.80%)
Artivion (NYSE:AORT) Delivers Strong Q2 CY2026 Numbers

Artivion (NYSE:AORT) Delivers Strong Q2 CY2026 Numbers

AORT : 28.41 (-0.80%)
Artivion Reports Second Quarter 2026 Financial Results

Second Quarter & Recent Business Highlights:

AORT : 28.41 (-0.80%)
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect

Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect

AORT : 28.41 (-0.80%)
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

NEO : 16.39 (-0.18%)
AORT : 28.41 (-0.80%)
OCUL : 10.10 (-1.27%)
3 Small-Cap Stocks We Keep Off Our Radar

3 Small-Cap Stocks We Keep Off Our Radar

OPAD : 4.52 (-2.80%)
UPLD : 6.10 (+20.55%)
AORT : 28.41 (-0.80%)
Artivion to Participate in Upcoming Investor Conferences

ATLANTA , July 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming...

AORT : 28.41 (-0.80%)
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results

ATLANTA , July 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT),  a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2026 financial...

AORT : 28.41 (-0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 31.01
2nd Resistance Point 30.17
1st Resistance Point 29.41
Last Price 28.41
1st Support Level 27.80
2nd Support Level 26.96
3rd Support Level 26.20

See More

52-Week High 48.25
Fibonacci 61.8% 37.14
Fibonacci 50% 33.71
Fibonacci 38.2% 30.27
Last Price 28.41
52-Week Low 19.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.